Literature DB >> 19925781

Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.

Annalisa Bruno1, Luigia Di Francesco, Isabella Coletta, Giorgina Mangano, Maria Alessandra Alisi, Lorenzo Polenzani, Claudio Milanese, Paola Anzellotti, Emanuela Ricciotti, Melania Dovizio, Andrea Di Francesco, Stefania Tacconelli, Marta L Capone, Paola Patrignani.   

Abstract

Inhibitors of microsomal prostaglandin (PG) E synthase-1 (mPGES-1) are being developed for the relief of pain. Redirection of the PGH(2) substrate to other PG synthases, found both in vitro and in vivo, in mPGES-1 knockout mice, may influence their efficacy and safety. We characterized the contribution of mPGES-1 to PGH(2) metabolism in lipopolysaccharide (LPS)-stimulated isolated human monocytes and whole blood by studying the synthesis of prostanoids [PGE(2), thromboxane (TX)B(2), PGF(2alpha) and 6-keto-PGF(1alpha)] and expression of cyclooxygenase (COX)-isozymes and down-stream synthases in the presence of pharmacological inhibition by the novel mPGES-1 inhibitor AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide]. AF3442 caused a concentration-dependent inhibition of PGE(2) in human recombinant mPGES-1 with an IC(50) of 0.06microM. In LPS-stimulated monocytes, AF3442 caused a concentration-dependent reduction of PGE(2) biosynthesis with an IC(50) of 0.41microM. At 1microM, AF3442 caused maximal selective inhibitory effect of PGE(2) biosynthesis by 61+/-3.3% (mean+/-SEM, P<0.01 versus DMSO vehicle) without significantly affecting other prostanoids (i.e. TXB(2), PGF(2alpha) and 6-keto-PGF(1alpha)). In LPS-stimulated whole blood, AF3442 inhibited in a concentration-dependent fashion inducible PGE(2) biosynthesis with an IC(50) of 29microM. A statistically significant inhibition of mPGES-1 activity was detected at 10 and 100microM (38+/-14%, P<0.05, and 69+/-5%, P<0.01, respectively). Up to 100microM, the other prostanoids were not significantly affected. In conclusion, AF3442 is a selective mPGES-1 inhibitor which reduced monocyte PGE(2) generation also in the presence of plasma proteins. Pharmacological inhibition of mPGES-1 did not translate into redirection of PGH(2) metabolism towards other terminal PG synthases in monocytes. The functional relevance of this observation deserves to be investigated in vivo. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925781     DOI: 10.1016/j.bcp.2009.11.011

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  19 in total

1.  Potential roles of microsomal prostaglandin E synthase-1 in rheumatoid arthritis.

Authors:  Fumiaki Kojima; Rahul G Matnani; Shinichi Kawai; Fumitaka Ushikubi; Leslie J Crofford
Journal:  Inflamm Regen       Date:  2011-03

2.  A Novel Selective Prostaglandin E2 Synthesis Inhibitor Relieves Pyrexia and Chronic Inflammation in Rats.

Authors:  Ryusuke Sugita; Harumi Kuwabara; Kotaro Sugimoto; Kazufumi Kubota; Yuichiro Imamura; Toshihiro Kiho; Atsushi Tengeiji; Katsuhiro Kawakami; Kohei Shimada
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

3.  Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases.

Authors:  Qian Wang; Yuanyuan Li; Mengying Wu; Songming Huang; Aihua Zhang; Yue Zhang; Zhanjun Jia
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

4.  Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.

Authors:  Zhonghua Xia; Aixia Yan
Journal:  Mol Divers       Date:  2017-05-08       Impact factor: 2.943

5.  Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis.

Authors:  Louise R Howe; Kotha Subbaramaiah; Claire V Kent; Xi K Zhou; Sung-Hee Chang; Timothy Hla; Per-Johan Jakobsson; Clifford A Hudis; Andrew J Dannenberg
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-04-25       Impact factor: 3.072

Review 6.  Mechanistic aspects of COX-2 expression in colorectal neoplasia.

Authors:  Dan A Dixon; Fernando F Blanco; Annalisa Bruno; Paola Patrignani
Journal:  Recent Results Cancer Res       Date:  2013

7.  Selective inhibitors of human mPGES-1 from structure-based computational screening.

Authors:  Ziyuan Zhou; Yaxia Yuan; Shuo Zhou; Kai Ding; Fang Zheng; Chang-Guo Zhan
Journal:  Bioorg Med Chem Lett       Date:  2017-06-29       Impact factor: 2.823

Review 8.  Identification and development of mPGES-1 inhibitors: where we are at?

Authors:  Hui-Hua Chang; Emmanuelle J Meuillet
Journal:  Future Med Chem       Date:  2011-11       Impact factor: 3.808

9.  Microsomal prostaglandin e synthase-1 in rheumatic diseases.

Authors:  Marina Korotkova; Per-Johan Jakobsson
Journal:  Front Pharmacol       Date:  2011-01-20       Impact factor: 5.810

10.  Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.

Authors:  Anna Kats; Tove Båge; Pierre Georgsson; Jörgen Jönsson; Hernán Concha Quezada; Anders Gustafsson; Leif Jansson; Claes Lindberg; Karin Näsström; Tülay Yucel-Lindberg
Journal:  FASEB J       Date:  2013-02-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.